[1]高 翔,刘 萨,文亚兰,等.外阴鳞癌组织中DCTN2 和HOXB7 水平表达及与预后的价值研究[J].现代检验医学杂志,2023,38(06):114-119.[doi:10.3969/j.issn.1671-7414.2023.06.021]
　GAO Xiang,LIU Sa,WEN Yalan,et al.Expression and Prognostic Value of DCTN2 and HOXB7 in Vulvar Squamous Cell Carcinoma[J].Journal of Modern Laboratory Medicine,2023,38(06):114-119.[doi:10.3969/j.issn.1671-7414.2023.06.021]
点击复制

外阴鳞癌组织中DCTN2 和HOXB7 水平表达及与预后的价值研究()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第38卷
期数:
2023年06期
页码:
114-119
栏目:
论著
出版日期:
2023-11-15

文章信息/Info

Title:
Expression and Prognostic Value of DCTN2 and HOXB7 in Vulvar Squamous Cell Carcinoma
文章编号:
1671-7414（2023）06-114-06
作者:
高 翔1; 刘 萨1; 文亚兰1; 黄仲禄2
（1. 江油市人民医院妇产科，四川江油 621700；2. 眉山市妇幼保健院妇科，四川眉山 620000）
Author(s):
GAO Xiang1;  LIU Sa1;  WEN Yalan1;  HUANG Zhonglu2
（1. Department of Gynaecology and Obstetrics，Jiangyou People’s Hospital, Sichuan Jiangyou 621700, China； 2. Department of Gynaecology, Meishan Maternal and Child Health Hospital, Sichuan Meishan 620000, China）
关键词:
动力蛋白激活蛋白2; 同源异型盒基因B7; 外阴鳞癌
分类号:
R737.35；R730.43
DOI:
10.3969/j.issn.1671-7414.2023.06.021
文献标志码:
A
摘要:
目的 探讨外阴鳞癌组织中动力蛋白激活蛋白2(dynactin2，DCTN2) 和同源异型盒基因B7(homeobox geneB7，HOXB7) 水平表达及与预后的价值研究。方法 收集2008 年1 月～ 2017 年12 月在江油市人民医院行手术治疗的132 例外阴鳞癌患者的癌组织与癌旁健康组织，采用免疫组织化学法检测组织中DCTN2 和HOXB7 表达情况；采用Kaplan-Meier 法分析外阴鳞癌患者癌组织DCTN2 和HOXB7 表达与五年生存率之间的关系；采用COX 回归分析外阴鳞癌患者五年后生存情况的影响因素。结果 外阴鳞癌组织中DCTN2 阳性表达低于癌旁健康组织(31.06% vs 71.21%)，HOXB7 阳性表达高于癌旁健康组织(65.91% vs 37.12% )，差异具有统计学意义(χ2=42.583，21.899，均P ＜ 0.05)。外阴鳞癌组织DCTN2 和HOXB7 表达与肿瘤FIGO 分期、淋巴结转移、淋巴结转移数量、分化程度和腹股沟淋巴结情况相关(χ2=16.998, 19.144; 6.983, 5.800; 6.595, 7.244; 6.076, 5.665; 5.864, 6.493, 均P ＜ 0.05)。Kaplan-Meier 生存曲线表明DCTN2 阳性表达外阴鳞癌患者生存率高于阴性表达患者(χ2=14.878，P ＜ 0.001),HOXB7 阳性表达患者生存率低于阴性表达患者(χ2=14.824，P ＜ 0.001)。多因素COX 分析结果显示，FIGO 分期、淋巴结转移、淋巴结转移数量、分化程度和HOXB7 表达均是导致外阴鳞癌患者五年死亡的危险因素(P ＜ 0.05)，DCTN2 表达为保护因素(P ＜ 0.05)。结论 外阴鳞癌患者癌组织DCTN2 表达下调，HOXB7 表达升高，其表达与患者五年生存预后密切相关。
Abstract:
Objective To explore the expression levels of dynactin2(DCTN2) and homeobox gene B7 (HOXB7) in vulvar squamous cell carcinoma tissue and their prognostic value. Methods The cancer tissues and adjacent healthy tissues of 132 patients with vaginal squamous cell carcinoma who underwent surgical treatment in Jiangyou People’s Hospital from January 2008 to December 2017 were collected, the expression of DCTN2 and HOXB7 was detected by immunohistochemistry. Kaplan- Meier method was applied to analyze the relationship between the expression of DCTN2, HOXB7 and 5-year survival rate in vulvar squamous cell carcinoma. COX regression was applied to analyze the influencing factors of survival of patients with vulvar squamous cell carcinoma after 5 years. Results The positive expression of DCTN2 in vulvar squamous cell carcinoma was lower than that in adjacent healthy tissues (31.06% vs 71.21% )，and the positive expression of HOXB7 was higher than that in adjacent healthy tissues (65.91% vs 37.12% ), the differences were statistically significant (χ2=42.583，21.899，all P<0.05). The expression of DCTN2 and HOXB7 in vulvar squamous cell carcinoma was correlated with tumor FIGO stage, lymph node metastasis, number of lymph node metastasis, degree of differentiation and inguinal lymph nodes (χ2=16.998, 19.144; 6.983, 5.800; 6.595, 7.244; 6.076, 5.665; 5.864, 6.493, all P<0.05). Kaplan-Meier survival curve showed that the survival rate of patients with DCTN2 positive vulvar squamous cell carcinoma was significantly higher than that of patients with negative expression (χ2=14.878，P<0.001), and the survival rate of patients with HOXB7 positive expression was lower than that of patients with negative expression (χ2=14.824，P<0.001). Multivariate COX analysis showed that FIGO stage, lymph node metastasis, number of lymph node metastasis, degree of differentiation, and expression of HOXB7 were all risk factors leading to 5-year death in patients with vulvar squamous cell carcinoma (P<0.05), while expression of DCTN2 was a protective factor (P<0.05). Conclusion The expression of DCTN2 was down-regulated and the expression of HOXB7 was increased in vulvar squamous cell carcinoma, which was closely related to the 5-year survival and prognosis of patients.

参考文献/References:

[1] 陈洁, 沈媛. 外阴鳞癌治疗新进展[J]. 中国计划生育和妇产科, 2021, 13(2): 29-32, 43. CHEN Jie, SHEN Yuan. New progress in the treatment of vulvar squamous cell carcinoma[J]. Chinese Journal of Family Planning & Gynecotokology, 2021, 13(2):29-32, 43.
[2] THUIJS N B, VAN BEURDEN M, BRUGGINK A H,et al. Vulvar intraepithelial neoplasia: incidence and long-term risk of vulvar squamous cell carcinoma[J].International Journal of Cancer, 2021, 148(1): 90-98.
[3] JULIA C J, HOANG L N. A review of prognostic factors in squamous cell carcinoma of the vulva:evidence from the last decade[J]. Seminars in Diagnostic Pathology, 2021, 38(1): 37-49.
[4] SU Xiaotao, LI Haoyu, CHEN Shaohua, et al. Study on the prognostic values of dynactin genes in low-grade glioma[J]. Technology in Cancer Research Treatment,2021, 20: 15330338211010143.
[5] 边毅, 吕金, 张谦, 等. 癌组织CD163 和动力蛋白激活蛋白2 表达与皮肤恶性黑色素瘤临床病理特征的关系[J]. 中华实用诊断与治疗杂志, 2021, 35(11):1128-1130. BIAN Yi, L? Jin, ZHANG Qian, et al. Correlations of CD163 and DCTN2 with the clinicopathological features of cutaneous malignant melanoma[J]. Journal of Chinese Practical Diagnosis and Therapy, 2021,35(11): 1128-1130.
[6] WU Xiang, LI Jin, YAN Tingyuan, et al. HOXB7 acts as an oncogenic biomarker in head and neck squamous cell carcinoma[J]. Cancer Cell International, 2021,21(1): 393.
[7] SHI Zhenfeng, ZHANG Hao, JIE Situ, et al. Long non-coding RNA SNHG8 promotes prostate cancer progression through repressing miR-384 and upregulating HOXB7[J]. Journal of Gene Medicine, 2021,23(3): e3309.
[8] 余红璐, 张莉, 汪朦朦, 等. 结直肠癌组织LASS2,HOXB7 蛋白表达与凋亡指数及预后的关系分析[J].现代生物医学进展, 2021, 21(17): 3383-3387. YU Honglu, ZHANG Li, WANG Mengmeng, et al. Expression of LASS2 and HOXB7 in colorectal cancer and its relationship with apoptosis index and prognosis[J]. Progress in Modern Biomedicine, 2021,21(17): 3383-3387.
[9] 谢玲玲, 林荣春, 冯凤芝, 等. 《2018 NCCN 外阴鳞癌临床实践指南( 第一版)》解读[J]. 中国实用妇科与产科杂志, 2017, 33(12): 1250-1254. XIE Lingling, LIN Rongchun, FENG Fengzhi, et al. Interpretation of 2018 NCCN clinical practice guidelines for vulvar squamous cell carcinoma(first edition)[J]. Chinese Journal of Practical Gynecology and Obstetrics, 2017, 33(12): 1250-1254.
[10] 张珊珊, 刘嗣同, 石洪爽, 等. 刺芒柄花素通过FAK/AKT/Bcl-2 通路促进外阴鳞癌SW962 细胞凋亡[J].解剖科学进展, 2021, 27(6): 653-656. ZHANG Shanshan, LIU Sitong, SHI Hongshuang, et al. Formononetin promotes apoptosis in vulvar squamous cell carcinoma SW962 cells through the FAK/AKT/Bcl-2 pathway[J]. Progress of Anatomical Sciences,2021, 27(6): 653-656.
[11] 王甜甜, 张蓉, 姚洪文, 等. 外阴鳞癌的临床病理特点及预后分析[J]. 中华肿瘤杂志, 2019, 41(5): 384-388. WANG Tiantian, ZHANG Rong, YAO Hongwen, et al. The clinicopathologic parameters and prognostic analysis of vulvar squamous cell carcinoma[J]. Chinese Journal of Oncology, 2019, 41(5): 384-388.
[12] SCAMPA M, KALBERMATTEN D F, ORANGES C M. Squamous cell carcinoma of the vulva: a survival and epidemiologic study with focus on surgery and radiotherapy[J]. Journal of Clinical Medicine, 2022,11(4): 1025.
[13] ROGERS L J. Management of advanced squamous cell carcinoma of the vulva[J]. Cancers, 2021, 14(1): 167.
[14] SANGHAVI P, KUMAR P, ROY A, et al. On and off controls within dynein-dynactin on native cargoes[J].Proceedings of the National Academy of Sciences of the United States of Ame, 2021, 118(23): e2103383118.
[15] 陈楷文, 华承薇, 袁宸, 等. 马链球菌兽疫亚种烯醇化酶对小鼠肺泡巨噬细胞吞噬功能的影响[J]. 畜牧兽医学报, 2020, 51(10): 2576-2583. CHEN Kaiwen, HUA Chengwei, YUAN Chen, et al. Effects of enolase of Streptococcus equi ssp. zooepidemicus on phagocytic functions of alveolar macrophages in mice[J]. Acta Veterinaria et Zootechnica Sinica, 2020, 51(10): 2576-2583.
[16] 王乔琦. 动力蛋白激活蛋白基因家族的表达在人皮肤黑色素瘤预后中的价值[D]. 南宁：广西医科大学,2019. WANG Qiaoqi .Prognostic value of dynactin gene family expression in skin cutaneous melanoma[D].Nanning：Guangxi Medical University, 2019.
[17] WANG Shijun, WANG Qiaoqi, ZHANG Xiqian, et al. Distinct prognostic value of dynactin subunit 4 (DCTN4) and diagnostic value of DCTN1, DCTN2,and DCTN4 in colon adenocarcinoma[J]. Cancer Management and Research, 2018, 10: 5807-5824.
[18] ZHOU Ting, FENG Zonghao, YANG Fan, et al. High expression of HOXB7 is an unfavorable prognostic factor for solid malignancies: a meta-analysis[J].Medicine(Baltimore), 2022, 101(3): e28564.
[19] HUO X Y, ZHANG X Y, YUAN F, et al. HOXB7 promotes proliferation and metastasis of glioma by regulating the Wnt/β-catenin pathway[J]. European Review for Medical and Pharmacological Sciences,2021, 25(8):3146.
[20] 于亮, 马波, 张升, 等. 血清核转录因子红系2 相关因子2 表达与非小细胞肺癌分期和增殖基因表达的相关性分析[J]. 中国医学前沿杂志( 电子版）, 2021,13(10): 139-143. YU Liang, MA Bo, ZHANG Sheng, et al. Correlation analysis of serum nuclear factor-erythroid 2-related factor 2 expression with staging and proliferative gene expression of non-small cell lung cancer[J]. Chinese Journal of the Frontiers of Medical Science(Electronic Version), 2021, 13(10): 139-143.
[21] 李莉玲, 符淳. 宫颈癌外周血单核细胞Toll 样受体4、核因子κB 表达变化与肿瘤增殖基因、侵袭基因的相关性[J]. 中国性科学, 2021, 30(9): 69-73. LI Liling, FU Chun. Correlation between TLR4/NF-κB in peripheral blood mononuclear cells of cervical cancer and tumor pro-liferation and invasion genes[J].Chinese Journal of Human Sexuality, 2021, 30(9): 69-73.
[22] 刘英, 何凤屏, 刘玉兰, 等. microRNA-214 靶向调控HOXB7 基因抑制结直肠癌细胞侵袭转移的机制与意义[J]. 中国当代医药, 2022, 29(18): 5-10. LIU Ying, HE Fengping, LIU Yulan, et al. Mechanism and significance of microRNA-214 targeted regulation of HOXB7 in inhibiting the invasion and metastasis of colorectal cancer cells[J]. China Modern Medicine,2022, 29(18): 5-10.
[23] DE BESSA GARCIA S A, ARA?JO M, PEREIRA T, et al. HOXB7 overexpression leads triple-negative breast cancer cells to a less aggressive phenotype [J].Biomedicines, 2021, 9(5):515.
[24] 蒋秋丽, 王佩红, 苗群英, 等. 宫颈鳞癌患者癌组织Nemo 样激酶的表达与临床病理特征及预后关系研究[J]. 现代检验医学杂志, 2019, 34(5): 72-76. JIANG Qiuli, WANG Peihong, MIAO Qunying, et al. Expression of NLK in cervical squamous cell carcinoma and its clinical significance[J]. Journal of Modern Laboratory Medicine, 2019, 34(5): 72-76.

备注/Memo

备注/Memo:
基金项目： 四川省妇幼医学科技创新课题（编号：22FXYB12)：基于亚甲蓝示踪法的腹股沟前哨淋巴结切除术在早期外阴癌手术中的临床价值。
作者简介：高翔(1984-)，女，本科，主治医师，研究方向：外阴癌，E-mail：mlp19870@126.com。
通讯作者：黄仲禄(1980-)，男，本科，副主任医师，研究方向：外阴癌。
更新日期/Last Update: 2023-11-15